genOway S.A.
ALGEN.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €22,059 | €20,046 | €17,053 | €14,019 |
| % Growth | 10% | 17.6% | 21.6% | – |
| Cost of Goods Sold | €12,805 | €1,243 | €18,363 | €17,765 |
| Gross Profit | -€1,885 | €18,804 | -€1,310 | -€3,746 |
| % Margin | -8.5% | 93.8% | -7.7% | -26.7% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €0 | €677 | €653 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €12,914 | €16,738 | €10,325 | €195 |
| Operating Expenses | €12,914 | €16,738 | €11,002 | €848 |
| Operating Income | €1,812 | €2,065 | €950 | -€4,595 |
| % Margin | 8.2% | 10.3% | 5.6% | -32.8% |
| Other Income/Exp. Net | -€5 | -€518 | -€191 | €518 |
| Pre-Tax Income | -€1,963 | €1,548 | €759 | -€4,077 |
| Tax Expense | -€3,794 | -€20 | -€2,698 | -€3,754 |
| Net Income | €1,831 | €1,568 | €778 | -€323 |
| % Margin | 8.3% | 7.8% | 4.6% | -2.3% |
| EPS | 0.19 | 0.17 | 0.088 | -0.037 |
| % Growth | 11.8% | 92.7% | 341% | – |
| EPS Diluted | 0.2 | 0.17 | 0.088 | -0.037 |
| Weighted Avg Shares Out | 9,482 | 9,026 | 8,820 | 8,824 |
| Weighted Avg Shares Out Dil | 9,482 | 9,026 | 8,820 | 8,824 |
| Supplemental Information | – | – | – | – |
| Interest Income | €258 | €36 | €3 | €252 |
| Interest Expense | €147 | €109 | €122 | €275 |
| Depreciation & Amortization | €2,590 | €4,287 | €2,335 | €1,924 |
| EBITDA | €3,894 | €6,351 | €537 | -€1,878 |
| % Margin | 17.7% | 31.7% | 3.1% | -13.4% |